Catalyst Wire Dossier Catalyst Wire Dossier

SARS-CoV-2 Alpha/Beta/Delta/Omicron Variants COVID-19 Vaccine

· Sinocelltech Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SARS-CoV-2 Alpha/Beta/Delta/Omicron Variants COVID-19 Vaccine, covering 2024-02-08 to 2024-02-08. Get the full timeline:

Most recent: Clinical Trial Update: A PhaseⅡ Study to Evaluate the Safety & Immunogenicity of SARS-CoV-2 Alpha/Beta/Delta/Omicron Variants COVID-19 Vaccine [Phase 2]

See pricing